Welcome to Europe's hottest event for investors.

Why attend HLTH Europe?

As Europe’s most important health event, HLTH Europe will be the first to unite every part of the European health ecosystem.

Connecting over 3,500 health leaders from over 50 countries, HLTH Europe will bring together key decision-makers across providers, payers, government, pharma, startups, investors and health tech. With one in three attendees at CEO/Founder level and two in three at Director level (or equivalent), HLTH Europe is the place where health does business.

Whether you're looking to uncover health’s newest and most exciting startup talent, forge your next partnership or learn about the latest advances in health, HLTH Europe is the only place you need to be in 2024.

Must attend investor sessions

Thrills, pills, and VC bills: What will it take to unleash innovation in the world of drug development

Drug development and rapid innovation are unlikely bedfellows.

Drug development is, by its very nature, a long-winded, wieldy, hyper-expensive process. However, the integration of artificial intelligence, high-throughput screening techniques, and advanced computational modelling has catalysed the identification of potential drug candidates and expedited the prediction of their efficacy and safety profiles.

Are we finally entering an era where the once-distant notions of drug development and rapid innovation are becoming increasingly intertwined? And what will it take for the industry to fully harness the potential of novel tools and strategies to address unmet medical needs in a more efficient and agile manner?

Blinded by AI: The Turing Test Live

In 1950, Alan Turing came up with The Imitation Game, later renamed in his honour.

The idea was simple. Imagine you have a conversation between a human A, and a computer programme B, through a text-based interface. Another human C is the judge. The judge's task is to have separate conversations with person A and programme B without seeing them, and then try to decide which one is the human and which one is the computer programme.

In this live blind Turing test panel, the audience is the judge, asked to work out who of our unsighted panellists is a human, and who is reading straight from a generative AI prompt.

Will you be able to work out who's shooting from the hip and who's words were written by a chip?

Missed the exit?: Health keeps on trucking despite IPO jam

In 2021, health was in cruise control. Ticking over at 130 km/h, with an IPO every few kilometres, a clear road ahead, and not a cloud in the sky. Looking back as 2020 disappeared in our mirrors we were forging ahead, free to forget about past issues and objections.

As we soared up to junction 2022 though, a jam appeared. Just one lane at first, then rapidly filling the highway. The skies grew darker. Warning lights started to appear. Slowly at first, then with rapid, debilitating, frequency. Objections in the mirror were indeed closer than they had appeared. If you looked just at the public markets, and their reaction to healthtech over the last two years, you could be forgiven for questioning whether an IPO is (still) a legitimate route for the sector.

With a number of high-profile firms down over 95% from their IPO, many have questioned whether this is indicative of a wider trend in venture-backed healthtech. After the SPAC-attack of 2021, and the subsequent fallout, and with VCs sat on more LP cash than ever before, can healthtech companies really still dream of an IPO? Or should they be set up to explore other exit routes?

Goldmine or fool’s gold?: Extracting value from health data

Healthcare data is a veritable feast - trillions of rows, across billions of patients, housed in millions of silos globally.

It's a little-known law, but healthtech startups are now legally required to have the phrase 'data-driven' somewhere on their website, just to be able to get a seat at the table (or the next round of investment). Data has transformed industries globally - from finance to shipping, energy to retail. Healthcare data has the power to transform our lives more than any other, but it’s still far from realising its maximum potential.

Underutilised, siloed, and mired in ethical and moral debate. To access the potential goldmine, the conversation has to finally move forward. Where will data make the most effective difference in healthcare? And how do we excavate this impenetrable goldmine?

Speaker highlights for investors

Alyssa Jaffee



Christian Angermayer


Apeiron Investment Group

United Kingdom

François-Xavier Duchateau

Group Chief Medical Officer

Allianz Partners


Heyo Kroemer


Charité – University Medicine Berlin


John Halamka

President, Mayo Clinic Platform
Mayo Clinic


Karen DeSalvo

Chief Health Officer



Funding Founders Programme

Join the free Funding Founders Programme and get matched with leading tech startup CEOs in 15-minute, 1:1 meetings.

Special programming

Unlock unparalleled networking opportunities, learn from industry experts and seize the chance to showcase your brand on a global stage.

Funding Founders

Designed to maximise time, efficiency and value, it’s never been easier to meet your next investment opportunity.

Join the programme free of charge and get matched with startup founders in 1:1 in 15-minute, structured meetings.

Startup Pitch

Hear from Europe's most exciting new startups, live on stage.

Our Startup Pitch, sponsored by Novo Nordisk will highlight Europe's boldest, brightest and most innovative startups.

Pitching their game-changing health solutions to a panel of judges at HLTH Europe for a chance to win €30,000, the competition will highlight Europe's most promising new talent. Previous winners have gone on to become tech unicorns.


Welcome to the place where health comes to party

Wednesday 19 June, we’re taking over Amsterdam’s incredible Westerpark for an evening like no other.

Set against a multi-venue backdrop, you can expect live music, DJ sets, immersive performances, incredible food and drinks and of course, the exclusive company of thousands of HLTH attendees.

Party with us!

Some call it our forte, others call it the secret sauce - but one thing's for sure, our legendary parties are the pinnacle of the HLTH experience.



7.30 PM



5.45 PM



7 PM



12.30 PM

See the investor agenda

With over 80 sessions and 300 speakers, we want to make sure you don't miss the most important sessions and programming for investors. We've created a investor-specific agenda, so you can plan your HLTH Europe experience effectively.

What's included with your ticket?

  • Access to all track and keynote sessions

  • HLTH Europe event app and attendee networking programme

  • All networking events, affinity meetups and receptions

  • All-inclusive breakfasts, lunches and refreshments throughout the day

  • Exhibit hall access, plus a full exhibitor directory

  • World-class entertainment, parties and live performances

  • Incredible memories, lasting connections and 3,500 new friends*

    *Number of new friends not guaranteed, but highly expected

Your next step

Secure your ticket now. The earlier you book, the lower the rate!

About HLTH Europe


HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.


2024 | HLTH Europe: 17-20 JUNE
2025 | HLTH Europe: 16-19 JUNE
2026 | HLTH Europe: 15-18 JUNE
2027 | HLTH Europe: 21-24 JUNE
2028 | HLTH Europe: 19-22 JUNE


2024 | ViVE: Feb 25-28

2024 | HLTH US: Oct 19-22

2025 | ViVE: Feb 16-19

2025 | HLTH US: Nov 15-18

2026 | HLTH US: Oct 17-20

Join the HLTH Europe mailing list